Moderna
Moderna Inc is an American biotechnology company pioneering messenger RNA therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune conditions. The company utilizes its proprietary mRNA platform and lipid nanoparticle delivery technology to instruct human cells to produce therapeutic proteins and target antigens. Its commercial portfolio features mRNA COVID-19 vaccines and respiratory syncytial virus vaccines, alongside a pipeline of investigational vaccines for influenza, cytomegalovirus, and personalized cancer treatments. Principal revenue is generated through product sales of mRNA vaccines, upfront licensing milestone payments, and government research grant funding. Moderna occupies a leading global position in mRNA biotechnology, supported by large-scale manufacturing facilities and global supply agreements. Headquartered in Cambridge, Massachusetts, the company's common stock is publicly listed and traded on the Nasdaq Global Select Market under the ticker MRNA.
10 of the funds FundTelligence covers report a position in Moderna.
- Legal name
- Moderna Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 10
Funds holding Moderna
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 6.52 % (full portfolio disclosed, October 2026)
- UBS Biotech Equity Fund — UBS · 6.4 % (largest positions only, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 6.25 % (full portfolio disclosed, October 2026)
- Allianz Global Equity Insights — Allianz Global Investors · 3.2 % (largest positions only, September 2026)
- BGF Next Generation Health Care Fund — BlackRock · 2.21 % (largest positions only, January 2026)
- SEB Nordamerikafond Små och Medelstora Bolag — SEB · 1.16 % (full portfolio disclosed, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.77 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.74 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 10 funds holding it.